A Rare Hematological Manifestation of Brucellosis: Reactive Hemophagocytic Syndrome  by Erduran, Erol et al.
Copyright © 2010 Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights reserved. 159
Contents lists available at ScienceDirect
Journal of Microbiology, Immunology and Infection
Journal homepage: http://www.e-jmii.com
J Microbiol Immunol Infect 2010;43(2):159–162
Microbiology, 
Infection
Immunology
Journal of 
and
  
Indexed in MEDLINE/Medicus, SCIE, BIOSIS, EMBASE,
Aidsline, CancerLit, Chemical Abstracts, HealthSTAR
Also available online http://www.e-jmii.com
The official journal of
Taiwan Society of Microbiology
Chinese Society of Immunology
The Infectious Diseases Society of Taiwan
Taiwan Society of Parasitology
ISSN 1684-1182
Volume 43
Number 2
April 2010
*Corresponding author. Department of Pediatric 
Hematology, School of Medicine, Karadeniz Technical 
University, 61080, Trabzon-Turkey.
E-mail: erolerduran@yahoo.com
Article History:
Received: Jul 11, 2008
Revised: Dec 1, 2008
Accepted: Dec 18, 2008
hMunc13-4 gene mutations, and usually occurs in infancy.1–3 
Secondary HS may occur in any age group and can develop 
as a result of malignancy, or metabolic, collagen vascular 
and infectious diseases such as brucellosis, miliary tuber-
culosis, Epstein-Barr virus, Cytomegalovirus, Parvovirus 
B19, human immunodeficiency virus, and some fungal 
infections.1,4,5 Both sporadic and familial cases of HS are 
often induced by acute infection. The diagnostic criteria 
for HS are high fever, hepatosplenomegaly, cytopenia (= 2 
cell types), high serum ferritin (> 500 μg/L), and elevated 
triglycerides (fasting triglyceride = 3 mmol/L), soluble CD25 
and soluble interleukin-2-receptor levels, low serum fibrin-
ogen (< 1.5g/L), decreased and absent Natural Killer-cell 
activity, and hemophagocytosis evident in the bone marrow 
or spleen.1,6
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Hemophagocytic syndrome (HS) may be primary, or secondary, to malignancy, or to metabolic, collagen 
vascular, and infectious diseases such as brucellosis, miliary tuberculosis and some viral and fungal infec-
tions. The diagnostic findings of HS are high fever, hepatosplenomegaly, cytopenia, high serum ferritin 
and triglycerides, and low serum fibrinogen levels. Brucellosis is a zoonotic disease, with fever, fatigue, 
sweating, arthritis, hepatosplenomegaly, lymphadenopathy, and cytopenia being the most common symp-
toms and findings. Hematological manifestations of the disease may include anemia, leucopenia, leuko-
cytosis, thrombocytopenia, and thrombocytosis. Brucellosis may occur in association with HS. Here, we 
describe brucellosis associated HS in an 8 year-old male patient. The patient was admitted to our clinic 
with weight loss, arthralgia, prolonged fever, sweating, and fatigue. Physical and laboratory findings re-
vealed hepatosplenomegaly, pancytopenia, elevated serum transaminases, triglycerides, lactate dehydro-
genase, and ferritin, and with erythrocytes, leukocytes, and thrombocytes phagocytosed by macrophages 
indicating hemophagocytosis. The Brucella agglutination test was positive. The patient improved after 
treatment with Rifampin (15 mg/kg/day) and trimethoprim-sulfamethoxazole (10 mg/kg/day).
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Introduction
Hemophagocytic syndrome (HS) is a hyperinflammatory 
condition with primary or secondary causes. Primary HS 
develops as a result of syntaxin 11, perforin 1, and 
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Brucellosis is an infectious disease of animals caused 
by coccobacilli of the genus Brucella, and is transmitted to 
humans by direct contact with infected animals, and by con-
sumption of infected animal products. In childhood the 
disease may present with many different symptoms and 
findings such as fever, fatigue, sweating, arthritis, hepato-
splenomegaly, lymphadenopathy, and cytopenia.7 Fever is 
the most common feature of brucellosis, followed by oste-
oarticular involvement and sweating.8 Genitourinary com-
plications such as glomerulonephritis, renal abscess and 
orchiepididymitis are seen in a few patients. Neurological 
findings like peripheral neuropathy, chorea, meningoen-
cephalitis, transient ischemic attacks, and psychiatric 
manifestations are not uncommon.8 Anemia, leukopenia, 
leukocytosis, thrombocytopenia, thrombocytosis, elevated 
C-reactive protein and erythrocyte sedimentation rate, 
and rheumatoid factor positivity can also be present. Ag g-
lutination tests and blood cultures are valuable for the di-
agnosis of brucellosis. A rare clinical presentation of human 
brucellosis is reactive HS.9 Reactive HS should be suspected 
if the patient presents with pancytopenia, hepatospleno-
megaly, prolonged fever, high serum triglyceride and ferritin 
levels, and low serum fibrinogen. Bone marrow aspiration 
should be performed to obtain a definitive diagnosis.
Here, we report the case of an 8 year-old child presenting 
with fever, abdominal pain, fatigue, sweating, and pancyto-
penia, resulting in a diagnosis of reactive HS associated with 
brucellosis.
Case Report
An 8 year-old boy was admitted to our pediatric hematology 
clinic with prolonged fever, fatigue, sweating, and abdomi-
nal pain. The fever and fatigue had started 1 month previ-
ously. He described abdominal pain, especially in the 
morning. There was no weight loss or arthralgia in the pa-
tient’s history, but he had ingested fresh milk products 
which were not cooked well. Physical examination revealed 
splenomegaly (a 3 cm increase in size) below the left costal 
edge and hepatomegaly (a 2 cm increase in size) below the 
right costal edge, pallor, and mild abdominal tenderness. 
Laboratory findings showed pancytopenia with hemo-
globin levels of 8.9 g/dL, white blood cell count of 2 × 109 
cells/L and a platelet count of 97 × 109 cells/L. The differ-
ential leukocyte count on the peripheral smear was 60% 
neutrophils, 35% lymphocytes, 5% monocytes. The reticulo-
cyte count was 2%. The erythrocyte sedimentation rate was 
18 mm/h. Biochemical analysis revealed alanine transami-
nase = 71 U/L, aspartate transaminase = 105 U/L, serum tri-
glyceride = 227 mg/dL, lactate hydrogenase (LDH) = 581 IU/L, 
ferritin = 1243 ng/mL and fibrinogen = 238 mg/dL. Other bio-
chemical findings were within normal limits. Serological 
tests performed for Epstein-Barr virus, Cytomegalovirus, and 
Salmonella were all negative. Bone marrow aspiration showed 
that lymphocytes, thrombocytes, and neutrophils had been 
phagocytosed by macrophages, indicating hemophagocy-
tosis (Figure). The Brucella agglutination test was positive 
with a ratio of 1:640. Blood and bone marrow cultures were 
also positive for Brucella. Reactive HS associated with bru-
cellosis was diagnosed according to the above laboratory 
and clinical findings. Rifampin (15 mg/kg/day) and tri-
methoprim-sulfamethoxazole (10 mg/kg/day) treatment 
was initiated. The fever disappeared on the third day of ther-
apy. The platelet count increased progressively during treat-
ment and, on Day 7, the blood count showed hemoglobin 
level = 9.2 g/dL, white blood cell count = 5.2 × 109 cells/L, and 
a platelet count of 281 × 109 cells/L. Biochemical abnor-
malities improved: serum triglyceride = 174 mg/dL, ferri-
tin = 142 ng/mL, alanine transaminase = 51 U/L, aspartate 
transaminase = 45 U/L and LDH = 328 IU/L. By Day 9 
splenomegaly was reduced to 1 cm in size, palpable below 
the left costal edge, and hepatomegaly was not detected. The 
patient was followed-up in the out-patient clinic for 6 weeks 
and fully recovered after treatment.
Figure. Bone marrow aspiration smear showing erythrocytes and 
thrombocytes phagocytosed by macrophages (Wright stain; 
original magnification, 100×).
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Discussion
Hemophagocytic syndrome is a hyperinflammatory disease 
and may develop primary to syntaxin 11, perforin 1, and 
hMunc13-4 gene mutations, or secondary to malignancy, 
and metabolic, collagen vascular and infectious diseases.1 
The cardinal symptoms and findings are fever unresponsive 
to antibiotics, fatigue, cytopenia, hepatosplenomegaly, and 
hemophagocytosis by activated macrophages.1,4 Icterus, 
rash, lymphadenopathy, and neurological symptoms may 
also be present. All the symptoms of HS can be explained 
by high concentrations of inflammatory cytokines such 
as interleukin-1, interleukin-6, tumor necrosis factor-α 
and interferon-γ.1 Laboratory findings include cytopenia, 
elevated serum triglycerides, ferritin and transaminase, 
and low serum fibrinogen levels.1,4 Tumor necrosis fac-
tor-α inhibits lipoprotein lipase leading to the elevation 
of triglycerides.1 The bone marrow smear usually shows 
evidence of hemophagocytosis in the majority of cases.
Hyperinflammation caused by excessive cytokine lev-
els should be treated with either corticosteroids or immu-
nosuppressive agents. Corticosteroids are cytotoxic for 
lymphocytes and inhibit the expression of cytokines. 
Intravenous immunoglobulins, etoposide, cyclosporin A, 
and antithymocyte globulin are the other treatment 
choices, either in combination with corticosteroids, or 
alone.1,6,10 The genetic form of HS usually occurs in chil-
dren below 1 year of age, and combination therapy with 
dexamethasone, cyclosporin A, etoposide, and intrathecal 
methotrexate is appropriate for this form of the disease. 
Infections associated with brucellosis and miliary tuberculo-
sis should be treated with the appropriate antibiotics.5,11
Various hematologic findings are seen in brucellosis. 
Especially, thrombocytopenia may be severe and steroid 
therapy is required in some cases.12 Pancytopenia is usually 
due to hypersplenism.13 In addition, granulomatous bone 
marrow lesions and hemophagocytosis in the bone mar-
row are thought to be the other causes for pancytopenia.14 
In an extensive investigation in Turkey, the hematological 
manifestations of 233 brucellosis cases were discussed, 
and anemia was the most common, followed by thrombo-
cytopenia and leukopenia.15 Also, pancytopenia and mild 
to moderate hemophagocytosis on the bone marrow smear 
were detected in 8% of the cases.15 In another study, 54 chil-
dren with brucellosis were evaluated, and pancytopenia 
was determined in 14.8% of them.11 Hemophagocytosis 
was detected in three of these cases. The pancytopenia was 
transient in all patients and resolved after appropriate anti-
biotic treatment. Our patient was treated with the combi-
nations of rifampin and trimethoprim-sulfamethoxazole. 
Tetracycline treatment was not appropriate for the patient 
because of his age. The patient recovered after antibiotic 
treatment.
Our patient presented with prolonged fever, fatigue, 
hepatosplenomegaly, and pancytopenia. Bone marrow aspi-
ration was done because the patient had pancytopenia, and 
high serum triglycerides, ferritin, and LDH. The bone mar-
row smear showed thrombocytes, neutrophils, and lym-
phocytes phagocytosed by macrophages. Reactive HS due 
to brucellosis was diagnosed as both blood and bone mar-
row aspiration cultures were positive for brucellosis, and the 
Brucella agglutination test was positive. Rifampin and tri-
methoprim-sulfamethoxazole treatment was initiated be-
cause the patient’s age was not appropriate for tetracycline 
treatment. The patient recovered after antibiotic treatment.
In patients with brucellosis coupled with hepatospleno-
megaly and cytopenia, an association with HS should be 
considered. Characteristic laboratory findings such as high 
serum ferritin and triglycerides, low serum fibrinogen levels, 
and pancytopenia support the diagnosis, and bone marrow 
aspiration should be performed. Evidence of hemophagocy-
tosis by activated macrophages on bone marrow smears is 
supportive of the diagnosis, but may not be present.1 Reactive 
hemophagocytosis should be considered in a patient having 
pancytopenia with brucellosis and early treatment with 
appropriate antibiotics will be life-saving.
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